Oral, not transdermal, estrogens raise thromboembolism risk

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1291, 2010-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral but not transdermal estrogens increase VTE risk

By  

Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

The risk of nonfatal venous thromboembolism (VTEs) appears to be similar with either transdermal or oral contraceptive (OC) use

By  

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Transdermal estradiol is comparable to oral conjugated estrogens for the relief of hot flushes

By  

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Oral HRT doubles venous thromboembolism risk

By  

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Randomised, Controlled Comparison of Transdermal Estradiol with Oral Conjugated Estrogens for the Relief of Hot Flushes

By Parsey K.   Ellman H.   Rahman M.  

Clinical Drug Investigation, Vol. 20, Iss. 4, 2000-10 ,pp. : 207-214

Adis International

Access to resources Recommend Favorite